The prevalence of factor VIII inhibitors and genetic aspects of inhibitor development in Chinese patients with haemophilia A

^*Shanghai Ruijin Hospital, Shanghai;^†Peking Union Hospital, Beijing;^‡China Institute of Hematology and Blood Disease Hospital, Tianjin;^§Anhui Provicial Hospital, Anhui;^¶Guangzhou Nanfang Hospital, Guangzhou; and^**Shandong Blood Center, Shandong, Republic of China